Overview on population screening for carriers with germline mutations in mismatch repair (MMR) genes in China (vol 19, 26, 2021)

doi:10.1186/s13053-021-00184-z

	Overview on population screening for carriers with germline mutations in mismatch repair (MMR) genes in China (vol 19, 26, 2021)
	Zhang, Min 1; Chen, Tianhui 2
刊名	HEREDITARY CANCER IN CLINICAL PRACTICE
	2021-05-17
卷号	19
ISSN号	1731-2302
DOI	10.1186/s13053-021-00184-z
通讯作者	Chen, Tianhui(chenth@zjcc.org.cn)
WOS研究方向	Oncology
语种	英语
出版者	BMC
WOS记录号	WOS:000651449600001
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/122116]
专题	中国科学院合肥物质科学研究院
通讯作者	Chen, Tianhui
作者单位	1.Hangzhou Med Coll, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China 2.Chinese Acad Sci, Univ Chinese Acad Sci, Inst Basic Med & Canc IBMC, Dept Canc Prevent,Expt Res Ctr,Canc Hosp,Zhejiang, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Zhang, Min,Chen, Tianhui. Overview on population screening for carriers with germline mutations in mismatch repair (MMR) genes in China (vol 19, 26, 2021)[J]. HEREDITARY CANCER IN CLINICAL PRACTICE,2021,19.
APA	Zhang, Min,&Chen, Tianhui.(2021).Overview on population screening for carriers with germline mutations in mismatch repair (MMR) genes in China (vol 19, 26, 2021).HEREDITARY CANCER IN CLINICAL PRACTICE,19.
MLA	Zhang, Min,et al."Overview on population screening for carriers with germline mutations in mismatch repair (MMR) genes in China (vol 19, 26, 2021)".HEREDITARY CANCER IN CLINICAL PRACTICE 19(2021).